Leaflet LANREOTIDA TERAPIA 60mg solution for injection in pre-filled syringe
Indicated for: acromegaly; neuroendocrine tumors
Route of administration: injectable
Substance: lanreotide (somatostatin analogue)
ATC: H01CB03 (Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Somatostatin and analogues)
Use during pregnancy only on medical advice.
Lanreotide is a somatostatin analog used to treat acromegaly and certain neuroendocrine tumors. It works by inhibiting the secretion of hormones such as growth hormone and reducing blood flow to neuroendocrine tumors.
The medication is administered as subcutaneous injections, usually once every 4 weeks, as directed by a doctor. The treatment is effective in controlling symptoms and slowing disease progression.
Side effects may include pain at the injection site, nausea, diarrhea, or fatigue. In rare cases, severe allergic reactions or gallstone formation may occur.
Patients should strictly follow their doctor's instructions and inform them about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
General data about LANREOTIDA TERAPIA 60mg
- Substance: lanreotide
- Date of latest medicines list: 01-08-2025
- Product code: W70962003
- Concentration: 60mg
- Pharmaceutical form: solution for injection in pre-filled syringe
- Quantity: 3
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for lanreotide
- 120mg
- 30mg
- 60mg
- 90mg